Gene Activity List

Home Icon Home Search Icon Search Alerts Icon Stocks Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Gene Compound Experiment Study Pathway Assay Report Bug Request Feature
Gene Activity List
You are on Page 73 of 1714:
63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83
Gene Compound Assay Inh Ic50 Ki View
5-hydroxytryptamine (serotonin) receptor 2B BENZO[E]PYRENE Serotonin 5-HT2B 46% NoneNone NoneNone View
epidermal growth factor receptor 3-METHYLCHOLANTHRENE Protein Tyrosine Kinase, EGF Receptor 46% NoneNone NoneNone View
adrenergic receptor, beta 2 CLOTRIMAZOLE Adrenergic beta2 46% NoneNone NoneNone View
arachidonate 15-lipoxygenase, second type AMRINONE Lipoxygenase 15-LO 46% NoneNone NoneNone View
arachidonate 15-lipoxygenase AMRINONE Lipoxygenase 15-LO 46% NoneNone NoneNone View
arachidonate 15-lipoxygenase AMRINONE Lipoxygenase 15-LO 46% NoneNone NoneNone View
cytochrome P450, family 2, subfamily C, polypeptide 9 NIFEDIPINE CYP450-2C9 Inhibition 46% NoneNone NoneNone View
Cytochrome P450, subfamily IIC (mephenytoin 4-hydroxylase) NIFEDIPINE CYP450-2C9 Inhibition 46% NoneNone NoneNone View
5-hydroxytryptamine (serotonin) receptor 1B TETRACAINE Serotonin 5-HT1B 46% NoneNone NoneNone View
aldo-keto reductase family 1, member B4 (aldose reductase) THIMEROSAL Aldose Reductase 46% NoneNone NoneNone View
aldo-keto reductase family 1, member B1 (aldose reductase) THIMEROSAL Aldose Reductase 46% NoneNone NoneNone View
aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase) THIMEROSAL Aldose Reductase 46% NoneNone NoneNone View
aldo-keto reductase family 7, member A3 (aflatoxin aldehyde reductase) THIMEROSAL Aldose Reductase 46% NoneNone NoneNone View
phosphodiesterase 3B BENZOTHIAZYL DISULFIDE Phosphodiesterase PDE3 46% NoneNone NoneNone View
phosphodiesterase 3A BENZOTHIAZYL DISULFIDE Phosphodiesterase PDE3 46% NoneNone NoneNone View
5-hydroxytryptamine (serotonin) receptor 3a DOXEPIN Serotonin 5-HT3 46% NoneNone NoneNone View
5-hydroxytryptamine (serotonin) receptor 3b DOXEPIN Serotonin 5-HT3 46% NoneNone NoneNone View
mitogen activated protein kinase 14 MC 288769 Protein Serine/Threonine Kinase, p38alpha 46% NoneNone NoneNone View
mitogen-activated protein kinase 14 MC 288769 Protein Serine/Threonine Kinase, p38alpha 46% NoneNone NoneNone View
solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2 TOLNAFTATE Adrenergic, Norepinephrine Transporter 46% NoneNone NoneNone View
arachidonate 15-lipoxygenase, second type PHENINDIONE Lipoxygenase 15-LO 46% NoneNone NoneNone View
arachidonate 15-lipoxygenase PHENINDIONE Lipoxygenase 15-LO 46% NoneNone NoneNone View
arachidonate 15-lipoxygenase PHENINDIONE Lipoxygenase 15-LO 46% NoneNone NoneNone View
phosphodiesterase 4A, cAMP specific TRIAMTERENE Phosphodiesterase PDE4 46% NoneNone NoneNone View
phosphodiesterase 4C, cAMP-specific TRIAMTERENE Phosphodiesterase PDE4 46% NoneNone NoneNone View
phosphodiesterase 4D TRIAMTERENE Phosphodiesterase PDE4 46% NoneNone NoneNone View
phosphodiesterase 4B, cAMP specific TRIAMTERENE Phosphodiesterase PDE4 46% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 8 GENISTEIN Calcium Channel Type L, Phenylalkylamine 46% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 7 GENISTEIN Calcium Channel Type L, Phenylalkylamine 46% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 6 GENISTEIN Calcium Channel Type L, Phenylalkylamine 46% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 5 GENISTEIN Calcium Channel Type L, Phenylalkylamine 46% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 4 GENISTEIN Calcium Channel Type L, Phenylalkylamine 46% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 3 GENISTEIN Calcium Channel Type L, Phenylalkylamine 46% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 2 GENISTEIN Calcium Channel Type L, Phenylalkylamine 46% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 1 GENISTEIN Calcium Channel Type L, Phenylalkylamine 46% NoneNone NoneNone View
sodium channel, voltage-gated, type 10, alpha polypeptide 1-(2-FLUOROBENZOYL)-4-(PHENYLMETHYL)-PIPERIDINE Sodium Channel, Site 2 44% NoneNone NoneNone View
sodium channel, voltage-gated, type IV, alpha polypeptide 1-(2-FLUOROBENZOYL)-4-(PHENYLMETHYL)-PIPERIDINE Sodium Channel, Site 2 44% NoneNone NoneNone View
sodium channel, voltage-gated, type V, alpha polypeptide 1-(2-FLUOROBENZOYL)-4-(PHENYLMETHYL)-PIPERIDINE Sodium Channel, Site 2 44% NoneNone NoneNone View
sodium channel, voltage-gated, type II, beta 1-(2-FLUOROBENZOYL)-4-(PHENYLMETHYL)-PIPERIDINE Sodium Channel, Site 2 44% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1 alpha 1-(2-FLUOROBENZOYL)-4-(PHENYLMETHYL)-PIPERIDINE Sodium Channel, Site 2 44% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1 gamma 1-(2-FLUOROBENZOYL)-4-(PHENYLMETHYL)-PIPERIDINE Sodium Channel, Site 2 44% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1 beta 1-(2-FLUOROBENZOYL)-4-(PHENYLMETHYL)-PIPERIDINE Sodium Channel, Site 2 44% NoneNone NoneNone View
sodium channel, voltage-gated, type 2, alpha 1 polypeptide 1-(2-FLUOROBENZOYL)-4-(PHENYLMETHYL)-PIPERIDINE Sodium Channel, Site 2 44% NoneNone NoneNone View
sodium channel, voltage-gated, type XI, alpha 1-(2-FLUOROBENZOYL)-4-(PHENYLMETHYL)-PIPERIDINE Sodium Channel, Site 2 44% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1, gamma 1-(2-FLUOROBENZOYL)-4-(PHENYLMETHYL)-PIPERIDINE Sodium Channel, Site 2 44% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1, delta 1-(2-FLUOROBENZOYL)-4-(PHENYLMETHYL)-PIPERIDINE Sodium Channel, Site 2 44% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1, beta (Liddle syndrome) 1-(2-FLUOROBENZOYL)-4-(PHENYLMETHYL)-PIPERIDINE Sodium Channel, Site 2 44% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1 alpha 1-(2-FLUOROBENZOYL)-4-(PHENYLMETHYL)-PIPERIDINE Sodium Channel, Site 2 44% NoneNone NoneNone View
sodium channel, voltage-gated, type X, alpha 1-(2-FLUOROBENZOYL)-4-(PHENYLMETHYL)-PIPERIDINE Sodium Channel, Site 2 44% NoneNone NoneNone View
sodium channel, voltage-gated, type IX, alpha 1-(2-FLUOROBENZOYL)-4-(PHENYLMETHYL)-PIPERIDINE Sodium Channel, Site 2 44% NoneNone NoneNone View
sodium channel, voltage gated, type VIII, alpha 1-(2-FLUOROBENZOYL)-4-(PHENYLMETHYL)-PIPERIDINE Sodium Channel, Site 2 44% NoneNone NoneNone View
sodium channel, voltage-gated, type VII, alpha 1-(2-FLUOROBENZOYL)-4-(PHENYLMETHYL)-PIPERIDINE Sodium Channel, Site 2 44% NoneNone NoneNone View
sodium channel, voltage-gated, type V, alpha (long QT syndrome 3) 1-(2-FLUOROBENZOYL)-4-(PHENYLMETHYL)-PIPERIDINE Sodium Channel, Site 2 44% NoneNone NoneNone View
sodium channel, voltage-gated, type IV, beta 1-(2-FLUOROBENZOYL)-4-(PHENYLMETHYL)-PIPERIDINE Sodium Channel, Site 2 44% NoneNone NoneNone View
sodium channel, voltage-gated, type IV, alpha 1-(2-FLUOROBENZOYL)-4-(PHENYLMETHYL)-PIPERIDINE Sodium Channel, Site 2 44% NoneNone NoneNone View
sodium channel, voltage-gated, type III, alpha 1-(2-FLUOROBENZOYL)-4-(PHENYLMETHYL)-PIPERIDINE Sodium Channel, Site 2 44% NoneNone NoneNone View
sodium channel, voltage-gated, type II, beta 1-(2-FLUOROBENZOYL)-4-(PHENYLMETHYL)-PIPERIDINE Sodium Channel, Site 2 44% NoneNone NoneNone View
sodium channel, voltage-gated, type II, alpha 2 1-(2-FLUOROBENZOYL)-4-(PHENYLMETHYL)-PIPERIDINE Sodium Channel, Site 2 44% NoneNone NoneNone View
sodium channel, voltage-gated, type I, beta 1-(2-FLUOROBENZOYL)-4-(PHENYLMETHYL)-PIPERIDINE Sodium Channel, Site 2 44% NoneNone NoneNone View
sodium channel, voltage-gated, type I, alpha 1-(2-FLUOROBENZOYL)-4-(PHENYLMETHYL)-PIPERIDINE Sodium Channel, Site 2 44% NoneNone NoneNone View
arachidonate 15-lipoxygenase, second type 1-NAPHTHYL ISOTHIOCYANATE Lipoxygenase 15-LO 44% NoneNone NoneNone View
arachidonate 15-lipoxygenase 1-NAPHTHYL ISOTHIOCYANATE Lipoxygenase 15-LO 44% NoneNone NoneNone View
arachidonate 15-lipoxygenase 1-NAPHTHYL ISOTHIOCYANATE Lipoxygenase 15-LO 44% NoneNone NoneNone View
cholinergic receptor, muscarinic 5 MITOXANTRONE Muscarinic M5 44% NoneNone NoneNone View
mitogen activated protein kinase 14 ITRACONAZOLE Protein Serine/Threonine Kinase, p38alpha 44% NoneNone NoneNone View
mitogen-activated protein kinase 14 ITRACONAZOLE Protein Serine/Threonine Kinase, p38alpha 44% NoneNone NoneNone View
cathepsin G IRINOTECAN Protease, Cathepsin G 44% NoneNone NoneNone View
mast cell protease 9 IRINOTECAN Protease, Cathepsin G 44% NoneNone NoneNone View
melanocortin 4 receptor L-744832 Melanocortin MC4 44% NoneNone NoneNone View
opioid receptor, sigma 1 QUINACRINE Sigma1 44% NoneNone NoneNone View
Sigma-2 Receptor CLORPRENALINE Sigma2 44% NoneNone NoneNone View
opioid receptor, kappa 1 D-TUBOCURARINE CHLORIDE Opiate kappa 44% NoneNone NoneNone View
adrenergic receptor, alpha 2a SERTRALINE Imidazoline I2, Central 44% NoneNone NoneNone View
adrenergic receptor, alpha 2c (Non-specific probe) SERTRALINE Imidazoline I2, Central 44% NoneNone NoneNone View
angiotensin II receptor, type 2 RITONAVIR Angiotensin AT2 44% NoneNone NoneNone View
5-hydroxytryptamine (serotonin) receptor 2C OXICONAZOLE Serotonin 5-HT2C 44% NoneNone NoneNone View
solute carrier family 28 (sodium-coupled nucleoside transporter), member 3 PAPAVERINE Adenosine Transporter 44% NoneNone NoneNone View
concentrative Na+ nucleoside cotransporter (DBSS) PAPAVERINE Adenosine Transporter 44% NoneNone NoneNone View
solute carrier family 28 (sodium-coupled nucleoside transporter), member 1 PAPAVERINE Adenosine Transporter 44% NoneNone NoneNone View
adenine nucleotide translocase (DBSS) (Non-specific probe) PAPAVERINE Adenosine Transporter 44% NoneNone NoneNone View
solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 4 PAPAVERINE Adenosine Transporter 44% NoneNone NoneNone View
Sigma-2 Receptor ONDANSETRON Sigma2 44% NoneNone NoneNone View
sodium channel, voltage-gated, type III, beta PRAMOXINE Sodium Channel, Site 2 44% NoneNone NoneNone View
sodium channel, voltage-gated, type I, alpha PRAMOXINE Sodium Channel, Site 2 44% NoneNone NoneNone View
sodium channel, voltage-gated, type IX, alpha PRAMOXINE Sodium Channel, Site 2 44% NoneNone NoneNone View
sodium channel, voltage-gated, type VII, alpha PRAMOXINE Sodium Channel, Site 2 44% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 7 CELECOXIB Calcium Channel Type L, Benzothiazepine 44% NoneNone NoneNone View
calcium channel, voltage-dependent, alpha2/delta subunit 1 BROMOCRIPTINE Calcium Channel Type L, Dihydropyridine 47% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1S subunit KETOCONAZOLE Calcium Channel Type L, Phenylalkylamine 47% NoneNone NoneNone View
calcium channel, voltage-dependent, alpha 1F subunit KETOCONAZOLE Calcium Channel Type L, Phenylalkylamine 47% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1D subunit KETOCONAZOLE Calcium Channel Type L, Phenylalkylamine 47% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1C subunit KETOCONAZOLE Calcium Channel Type L, Phenylalkylamine 47% NoneNone NoneNone View
solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2 S-(N-BENZYLTHIOCARBAMOYL)-L-CYSTEINE Adrenergic, Norepinephrine Transporter 47% NoneNone NoneNone View
tachykinin receptor 2 FENOFIBRATE Tachykinin NK2 47% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1D subunit ERGOCORNINE Calcium Channel Type L, Dihydropyridine 47% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1C subunit ERGOCORNINE Calcium Channel Type L, Dihydropyridine 47% NoneNone NoneNone View
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit ERGOCORNINE Calcium Channel Type L, Dihydropyridine 47% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 1 subunit ERGOCORNINE Calcium Channel Type L, Dihydropyridine 47% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1E subunit ERGOCORNINE Calcium Channel Type L, Dihydropyridine 47% NoneNone NoneNone View
calcium channel, voltage-dependent, N type, alpha 1B subunit ERGOCORNINE Calcium Channel Type L, Dihydropyridine 47% NoneNone NoneNone View
calcium channel, voltage-dependent, alpha2/delta subunit 1 ERGOCORNINE Calcium Channel Type L, Dihydropyridine 47% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 8 ERGOCORNINE Calcium Channel Type L, Dihydropyridine 47% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 7 ERGOCORNINE Calcium Channel Type L, Dihydropyridine 47% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 6 ERGOCORNINE Calcium Channel Type L, Dihydropyridine 47% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 5 ERGOCORNINE Calcium Channel Type L, Dihydropyridine 47% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 4 ERGOCORNINE Calcium Channel Type L, Dihydropyridine 47% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 3 ERGOCORNINE Calcium Channel Type L, Dihydropyridine 47% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 2 ERGOCORNINE Calcium Channel Type L, Dihydropyridine 47% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 1 ERGOCORNINE Calcium Channel Type L, Dihydropyridine 47% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 4 subunit ERGOCORNINE Calcium Channel Type L, Dihydropyridine 47% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 3 subunit ERGOCORNINE Calcium Channel Type L, Dihydropyridine 47% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 2 subunit ERGOCORNINE Calcium Channel Type L, Dihydropyridine 47% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1S subunit ERGOCORNINE Calcium Channel Type L, Dihydropyridine 47% NoneNone NoneNone View
calcium channel, voltage-dependent, alpha 1F subunit ERGOCORNINE Calcium Channel Type L, Dihydropyridine 47% NoneNone NoneNone View
cytochrome P450, family 3, subfamily a, polypeptide 13 AURANOFIN CYP450-3A4 Inhibition 47% NoneNone NoneNone View
solute carrier family 28 (sodium-coupled nucleoside transporter), member 3 LY-294002 Adenosine Transporter 47% NoneNone NoneNone View
concentrative Na+ nucleoside cotransporter (DBSS) LY-294002 Adenosine Transporter 47% NoneNone NoneNone View
solute carrier family 28 (sodium-coupled nucleoside transporter), member 1 LY-294002 Adenosine Transporter 47% NoneNone NoneNone View
adenine nucleotide translocase (DBSS) (Non-specific probe) LY-294002 Adenosine Transporter 47% NoneNone NoneNone View
solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 4 LY-294002 Adenosine Transporter 47% NoneNone NoneNone View
sodium channel, voltage-gated, type IX, alpha ESTRONE Sodium Channel, Site 2 47% NoneNone NoneNone View
sodium channel, voltage gated, type VIII, alpha ESTRONE Sodium Channel, Site 2 47% NoneNone NoneNone View
sodium channel, voltage-gated, type VII, alpha ESTRONE Sodium Channel, Site 2 47% NoneNone NoneNone View
sodium channel, voltage-gated, type V, alpha (long QT syndrome 3) ESTRONE Sodium Channel, Site 2 47% NoneNone NoneNone View
sodium channel, voltage-gated, type IV, beta ESTRONE Sodium Channel, Site 2 47% NoneNone NoneNone View
sodium channel, voltage-gated, type IV, alpha ESTRONE Sodium Channel, Site 2 47% NoneNone NoneNone View
sodium channel, voltage-gated, type III, alpha ESTRONE Sodium Channel, Site 2 47% NoneNone NoneNone View
sodium channel, voltage-gated, type II, beta ESTRONE Sodium Channel, Site 2 47% NoneNone NoneNone View
sodium channel, voltage-gated, type II, alpha 2 ESTRONE Sodium Channel, Site 2 47% NoneNone NoneNone View
sodium channel, voltage-gated, type I, beta ESTRONE Sodium Channel, Site 2 47% NoneNone NoneNone View
sodium channel, voltage-gated, type I, alpha ESTRONE Sodium Channel, Site 2 47% NoneNone NoneNone View
sodium channel, voltage-gated, type IV, beta ESTRONE Sodium Channel, Site 2 47% NoneNone NoneNone View
sodium channel associated protein 1 ESTRONE Sodium Channel, Site 2 47% NoneNone NoneNone View
sodium channel associated protein 2 ESTRONE Sodium Channel, Site 2 47% NoneNone NoneNone View
sodium channel, voltage-gated, type III, beta ESTRONE Sodium Channel, Site 2 47% NoneNone NoneNone View
sodium channel, voltage-gated, type I, alpha ESTRONE Sodium Channel, Site 2 47% NoneNone NoneNone View
sodium channel, voltage-gated, type IX, alpha ESTRONE Sodium Channel, Site 2 47% NoneNone NoneNone View
sodium channel, voltage-gated, type VII, alpha ESTRONE Sodium Channel, Site 2 47% NoneNone NoneNone View
amiloride-sensitive cation channel 5, intestinal ESTRONE Sodium Channel, Site 2 47% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 4 subunit GENISTEIN Calcium Channel Type L, Phenylalkylamine 46% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 3 subunit GENISTEIN Calcium Channel Type L, Phenylalkylamine 46% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 2 subunit GENISTEIN Calcium Channel Type L, Phenylalkylamine 46% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1S subunit GENISTEIN Calcium Channel Type L, Phenylalkylamine 46% NoneNone NoneNone View
calcium channel, voltage-dependent, alpha 1F subunit GENISTEIN Calcium Channel Type L, Phenylalkylamine 46% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1D subunit GENISTEIN Calcium Channel Type L, Phenylalkylamine 46% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1C subunit GENISTEIN Calcium Channel Type L, Phenylalkylamine 46% NoneNone NoneNone View
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit GENISTEIN Calcium Channel Type L, Phenylalkylamine 46% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 1 SILDENAFIL Calcium Channel Type L, Benzothiazepine 46% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 4 subunit SILDENAFIL Calcium Channel Type L, Benzothiazepine 46% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 3 subunit SILDENAFIL Calcium Channel Type L, Benzothiazepine 46% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 2 subunit SILDENAFIL Calcium Channel Type L, Benzothiazepine 46% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1S subunit SILDENAFIL Calcium Channel Type L, Benzothiazepine 46% NoneNone NoneNone View
calcium channel, voltage-dependent, alpha 1F subunit SILDENAFIL Calcium Channel Type L, Benzothiazepine 46% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1D subunit SILDENAFIL Calcium Channel Type L, Benzothiazepine 46% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1C subunit SILDENAFIL Calcium Channel Type L, Benzothiazepine 46% NoneNone NoneNone View
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit SILDENAFIL Calcium Channel Type L, Benzothiazepine 46% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 1 subunit SILDENAFIL Calcium Channel Type L, Benzothiazepine 46% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1E subunit SILDENAFIL Calcium Channel Type L, Benzothiazepine 46% NoneNone NoneNone View
calcium channel, voltage-dependent, N type, alpha 1B subunit SILDENAFIL Calcium Channel Type L, Benzothiazepine 46% NoneNone NoneNone View
calcium channel, voltage-dependent, alpha2/delta subunit 1 SILDENAFIL Calcium Channel Type L, Benzothiazepine 46% NoneNone NoneNone View
cholinergic receptor, muscarinic 4 IDARUBICIN Muscarinic M4 46% NoneNone NoneNone View
adrenergic receptor, alpha 2b PROPAFENONE Adrenergic alpha2C 46% NoneNone NoneNone View
adrenergic receptor, alpha 2c (Non-specific probe) PROPAFENONE Adrenergic alpha2C 46% NoneNone NoneNone View
sodium channel, voltage-gated, type XI, alpha SALICYLAMIDE Sodium Channel, Site 2 10% NoneNone NoneNone View
solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2 PERGOLIDE Adrenergic, Norepinephrine Transporter 46% NoneNone NoneNone View
adrenergic receptor, alpha 2a HYDROXYCHLOROQUINE Adrenergic alpha2A 46% NoneNone NoneNone View
cholinergic receptor, muscarinic 3 GW-1929 Muscarinic M3 46% NoneNone NoneNone View
angiotensin II receptor, type 2 GW-1929 Angiotensin AT2 46% NoneNone NoneNone View
5-hydroxytryptamine (serotonin) receptor 1B METOCLOPRAMIDE Serotonin 5-HT1B 46% NoneNone NoneNone View
Cytochrom P450-2D6 monooxygenase S-(-)-PROPRANOLOL CYP450-2D6 Inhibition 46% NoneNone NoneNone View
adrenergic receptor, alpha 1b NOVARTIS P-38 INHIBITOR Adrenergic alpha1B 46% NoneNone NoneNone View
gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 4 MICONAZOLE GABAA, Chloride Channel, TBOB 46% NoneNone NoneNone View
gamma-aminobutyric acid A receptor, gamma 1 MICONAZOLE GABAA, Chloride Channel, TBOB 46% NoneNone NoneNone View
gamma-aminobutyric acid A receptor, pi MICONAZOLE GABAA, Chloride Channel, TBOB 46% NoneNone NoneNone View
AT hook, DNA binding motif, containing 1 (DBSS) MICONAZOLE GABAA, Chloride Channel, TBOB 46% NoneNone NoneNone View
gamma-aminobutyric acid A receptor, theta MICONAZOLE GABAA, Chloride Channel, TBOB 46% NoneNone NoneNone View
gamma-aminobutyric acid A receptor, gamma 2 MICONAZOLE GABAA, Chloride Channel, TBOB 46% NoneNone NoneNone View
gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 6 MICONAZOLE GABAA, Chloride Channel, TBOB 46% NoneNone NoneNone View
gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 5 MICONAZOLE GABAA, Chloride Channel, TBOB 46% NoneNone NoneNone View
gamma-aminobutyric acid A receptor, alpha 2 MICONAZOLE GABAA, Chloride Channel, TBOB 46% NoneNone NoneNone View
gamma-aminobutyric acid A receptor, alpha 1 MICONAZOLE GABAA, Chloride Channel, TBOB 46% NoneNone NoneNone View
gamma-aminobutyric acid (GABA-C) receptor, subunit rho 2 MICONAZOLE GABAA, Chloride Channel, TBOB 46% NoneNone NoneNone View
gamma-aminobutyric acid (GABA-C) receptor, subunit rho 1 MICONAZOLE GABAA, Chloride Channel, TBOB 46% NoneNone NoneNone View
gamma-aminobutyric acid A receptor, delta MICONAZOLE GABAA, Chloride Channel, TBOB 46% NoneNone NoneNone View
gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 3 MICONAZOLE GABAA, Chloride Channel, TBOB 46% NoneNone NoneNone View
5-hydroxytryptamine (serotonin) receptor 2A KETOCONAZOLE Serotonin 5-HT2A 46% NoneNone NoneNone View
solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2 BENZO[A]PYRENE Adrenergic, Norepinephrine Transporter 46% NoneNone NoneNone View
Cytochrom P450-1A2 monooxygenase S-(N-BENZYLTHIOCARBAMOYL)-L-CYSTEINE CYP450-1A2 Inhibition 46% NoneNone NoneNone View
Cytochrom P450-2D6 monooxygenase KETOCONAZOLE CYP450-2D6 Inhibition 46% NoneNone NoneNone View
5-hydroxytryptamine (serotonin) receptor 1B DEXCHLORPHENIRAMINE Serotonin 5-HT1B 46% NoneNone NoneNone View
dopamine receptor D1A FENOFIBRATE Dopamine D1 46% NoneNone NoneNone View
progesterone receptor SULCONAZOLE Progesterone 46% NoneNone NoneNone View
progesterone receptor SULCONAZOLE Progesterone 46% NoneNone NoneNone View
androgen receptor S-(N-BENZYLTHIOCARBAMOYL)-L-CYSTEINE Testosterone 44% NoneNone NoneNone View
opioid receptor, delta 1 ZAPRINAST Opiate delta 44% NoneNone NoneNone View
mitogen activated protein kinase 3 BENZO[A]PYRENE Protein Serine/Threonine Kinase, ERK1 44% NoneNone NoneNone View
mitogen-activated protein kinase 3 BENZO[A]PYRENE Protein Serine/Threonine Kinase, ERK1 44% NoneNone NoneNone View
5-hydroxytryptamine (serotonin) receptor 2B DANAZOL Serotonin 5-HT2B 44% NoneNone NoneNone View
dopamine receptor D4 SULCONAZOLE Dopamine D4.2 44% NoneNone NoneNone View
Cytochrom P450-1A2 monooxygenase DIMETHYL SULFOXIDE CYP450-1A2 Inhibition 44% NoneNone NoneNone View